These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8758948)

  • 1. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies.
    Piallat B; Benazzouz A; Benabid AL
    Eur J Neurosci; 1996 Jul; 8(7):1408-14. PubMed ID: 8758948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease.
    Rizelio V; Szawka RE; Xavier LL; Achaval M; Rigon P; Saur L; Matheussi F; Delattre AM; Anselmo-Franci JA; Meneses M; Ferraz AC
    Braz J Med Biol Res; 2010 Jan; 43(1):85-95. PubMed ID: 19967265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions.
    Chen L; Liu Z; Tian Z; Wang Y; Li S
    Stereotact Funct Neurosurg; 2000; 75(2-3):66-75. PubMed ID: 11740172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior.
    Anaya-Martinez V; Martinez-Marcos A; Martinez-Fong D; Aceves J; Erlij D
    Neuroscience; 2006 Dec; 143(2):477-86. PubMed ID: 17008017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions.
    Tseng KY; Riquelme LA; Belforte JE; Pazo JH; Murer MG
    Eur J Neurosci; 2000 Jan; 12(1):247-56. PubMed ID: 10651879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
    Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
    Kirik D; Rosenblad C; Björklund A
    Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats.
    Delfs JM; Ciaramitaro VM; Parry TJ; Chesselet MF
    J Neurosci; 1995 Oct; 15(10):6562-75. PubMed ID: 7472418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degeneration of pre-labelled nigral neurons induced by intrastriatal 6-hydroxydopamine in the rat: behavioural and biochemical changes and pretreatment with the calcium-entry blocker nimodipine.
    Sautter J; Kupsch A; Earl CD; Oertel WH
    Exp Brain Res; 1997 Oct; 117(1):111-9. PubMed ID: 9386009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.
    Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
    Synapse; 2001 May; 40(2):145-53. PubMed ID: 11252026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat.
    Lee CS; Sauer H; Bjorklund A
    Neuroscience; 1996 Jun; 72(3):641-53. PubMed ID: 9157311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
    J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease.
    Piallat B; Benazzouz A; Benabid AL
    J Neural Transm Suppl; 1999; 55():71-7. PubMed ID: 10335494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural effects of subthalamic nucleus lesions in the hemiparkinsonian marmoset (Callithrix jacchus).
    Henderson JM; Annett LE; Torres EM; Dunnett SB
    Eur J Neurosci; 1998 Feb; 10(2):689-98. PubMed ID: 9749730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus.
    Honey CR; Shen H
    Neurosci Lett; 1998 Jun; 249(2-3):151-4. PubMed ID: 9682839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.
    Henderson JM; Stanic D; Tomas D; Patch J; Horne MK; Bourke D; Finkelstein DI
    Behav Brain Res; 2005 May; 160(2):267-76. PubMed ID: 15863223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
    Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.